AFK-PD alleviated osteoarthritis progression by chondroprotective and anti-inflammatory activity
Osteoarthritis (OA) is the most prevalent cartilage degenerative and low-grade inflammatory disease of the whole joint. However, there are currently no FDA-approved drugs or global regulatory agency-approved treatments OA disease modification. Therefore, it's essential to explore novel effectiv...
Saved in:
Main Authors: | Zhuang Qian (Author), Jie Xu (Author), Lei Zhang (Author), Qian Deng (Author), Zhenlin Fan (Author), Xueqiang Guo (Author), Zhuo Liang (Author), Weiyun Wang (Author), Lei Wang (Author), Xiaohua Liao (Author), Wenjie Ren (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of chondroprotective agents to inhibit osteodestructive processes in the subchondral bone in patients with osteoarthritis
by: О. А. Gromova, et al.
Published: (2022) -
Bioactive components and potential mechanisms of Biqi Capsule in the treatment of osteoarthritis: based on chondroprotective and anti-inflammatory activity
by: Ziyue Jia, et al.
Published: (2024) -
A putative Chondroprotective role for IL-1β and MPO in herbal treatment of experimental osteoarthritis
by: Nora M. Aborehab, et al.
Published: (2017) -
Chondroprotective Effects of 4,5-Dicaffeoylquinic Acid in Osteoarthritis through NF-κB Signaling Inhibition
by: Goeun Jang, et al.
Published: (2022) -
Evaluation of the effect of an ayurvedic formulation Myostaal Forte tablets on chondroprotective biomarkers in an experimental model of osteoarthritis in rats
by: Shetty YC, et al.
Published: (2021)